Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 3
1975 5
1976 12
1977 13
1978 9
1979 26
1980 18
1981 11
1982 17
1983 32
1984 29
1985 19
1986 50
1987 34
1988 28
1989 29
1990 28
1991 20
1992 38
1993 32
1994 24
1995 34
1996 22
1997 20
1998 31
1999 30
2000 21
2001 24
2002 21
2003 24
2004 14
2005 23
2006 22
2007 18
2008 21
2009 14
2010 16
2011 12
2012 15
2013 17
2014 17
2015 10
2016 13
2017 8
2018 15
2019 7
2020 4
2021 2
2022 4
2023 2
2024 1
2025 3
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

936 results

Results by year

Filters applied: . Clear all
Page 1
Lung Health Study.
Anthonisen NR. Anthonisen NR. Am Rev Respir Dis. 1989 Oct;140(4):871-2. doi: 10.1164/ajrccm/140.4.871. Am Rev Respir Dis. 1989. PMID: 2529803 Clinical Trial. No abstract available.
Evaluation and Comparison of the Effectiveness of Atropine Eye Drops, Ipratropium Bromide Nasal Spray, and Amitriptyline Tablet in the Management of Clozapine-Associated Sialorrhea in Patients With Refractory Schizophrenia: A Randomized Clinical Trial.
Mohammad-Gholizad F, Karimzadeh I, Moghimi-Sarani E, Arshadi M, Mortazavi N. Mohammad-Gholizad F, et al. J Clin Psychopharmacol. 2024 Jan-Feb 01;44(1):9-15. doi: 10.1097/JCP.0000000000001786. J Clin Psychopharmacol. 2024. PMID: 38100776 Clinical Trial.
In this study, 2 topical agents (atropine eye drop and ipratropium nasal spray) and a systemic medication (amitriptyline) were compared simultaneously for the management of clozapine-associated sialorrhea. ...RESULTS: Twenty-four patients, including 6, 10, and 8 individual …
In this study, 2 topical agents (atropine eye drop and ipratropium nasal spray) and a systemic medication (amitriptyline) were compar …
Salbutamol and ipratropium by inhaler is superior to nebulizer in children with severe acute asthma exacerbation: Randomized clinical trial.
Iramain R, Castro-Rodriguez JA, Jara A, Cardozo L, Bogado N, Morinigo R, De Jesús R. Iramain R, et al. Pediatr Pulmonol. 2019 Apr;54(4):372-377. doi: 10.1002/ppul.24244. Epub 2019 Jan 22. Pediatr Pulmonol. 2019. PMID: 30672140 Clinical Trial.
One group received salbutamol and ipratropium (two puff every 10 min for 2 h and then every 30 min for 2 h more) by MDI with a valved-holding chamber and mask along with oxygen by a cannula separately (MDI-SIB); and the other received nebulization with oxygen (NEB-SIB) of …
One group received salbutamol and ipratropium (two puff every 10 min for 2 h and then every 30 min for 2 h more) by MDI with a valved …
Clinical and Inflammatory Benefits of Nebulized Furosemide with Salbutamol-Ipratropium in COPD Exacerbations: A Randomized Controlled Trial.
Behi M, Gholamine B, Masjedi MR, Eslaminejad A, Idani E, Sadeghi M, Qanavati A, Marashian SM, Mortaz E, Abedini A, Pourabdollah M, Pakshad B, Mahmoodian S. Behi M, et al. Iran J Allergy Asthma Immunol. 2026 Aug 12;25(Sup 11):112-128. doi: 10.18502/ijaai.v25is11.22488. Iran J Allergy Asthma Immunol. 2026. PMID: 42825900 Clinical Trial.
This study evaluated nebulized furosemide, which has bronchodilatory and anti-inflammatory effects, as an adjunct to salbutamol-ipratropium in hospitalized COPD patients. Ninety-two patients with exacerbated COPD were randomly assigned to two equal groups (46 each). The in …
This study evaluated nebulized furosemide, which has bronchodilatory and anti-inflammatory effects, as an adjunct to salbutamol-ipratropi …
Ipratropium.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1987 Jul 31;29(745):71-2. Med Lett Drugs Ther. 1987. PMID: 2885730 Clinical Trial. No abstract available.
Randomized pilot trial of ipratropium versus placebo in children with critical asthma.
Murphy K, Mahmood N, Craven D, Gallagher J, Ross K, Speicher R, Rotta AT, Shein SL. Murphy K, et al. Pediatr Pulmonol. 2020 Dec;55(12):3287-3292. doi: 10.1002/ppul.25115. Epub 2020 Oct 21. Pediatr Pulmonol. 2020. PMID: 33049119 Clinical Trial.
OBJECTIVE: To test the effects of inhaled ipratropium on clinical outcomes of critical asthma in the first randomized trial of this adjunctive therapy in critically ill children. ...A larger, multicenter trial is warranted to confirm that ipratropium does not improv …
OBJECTIVE: To test the effects of inhaled ipratropium on clinical outcomes of critical asthma in the first randomized trial of this a …
The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD.
Dorinsky PM, Reisner C, Ferguson GT, Menjoge SS, Serby CW, Witek TJ Jr. Dorinsky PM, et al. Chest. 1999 Apr;115(4):966-71. doi: 10.1378/chest.115.4.966. Chest. 1999. PMID: 10208193 Clinical Trial.
STUDY OBJECTIVES: To determine whether the combination of ipratropium bromide and albuterol results in greater and more consistent pulmonary function test (PFT) response rates than ipratropium bromide or albuterol alone in patients with COPD. ...PATIENTS: A total of …
STUDY OBJECTIVES: To determine whether the combination of ipratropium bromide and albuterol results in greater and more consistent pu …
A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis.
Bronsky EA, Druce H, Findlay SR, Hampel FC, Kaiser H, Ratner P, Valentine MD, Wood CC. Bronsky EA, et al. J Allergy Clin Immunol. 1995 May;95(5 Pt 2):1117-22. doi: 10.1016/s0091-6749(95)70215-6. J Allergy Clin Immunol. 1995. PMID: 7751528 Clinical Trial.
The purpose of the present trial was to study the safety and efficacy of a new isotonic aqueous ipratropium bromide nasal spray pump, specifically in patients with perennial nonallergic rhinitis. Two hundred thirty-three patients participated in an 8-week double-blind para …
The purpose of the present trial was to study the safety and efficacy of a new isotonic aqueous ipratropium bromide nasal spray pump, …
Effects of ipratropium on exercise-induced bronchospasm.
Boaventura LC, Araujo AC, Martinez JB, Vianna EO. Boaventura LC, et al. Int J Sports Med. 2010 Jul;31(7):516-20. doi: 10.1055/s-0030-1249624. Epub 2010 May 12. Int J Sports Med. 2010. PMID: 20464647 Clinical Trial.
We hypothesized that time of administration of ipratropium interferes with its action. This was a prospective, double-blind, cross-over study carried out to evaluate the bronchoprotective and bronchodilatory effect of ipratropium at different times of day. ...In the …
We hypothesized that time of administration of ipratropium interferes with its action. This was a prospective, double-blind, cross-ov …
Nebulized Ipratropium bromide protects against tracheal and bronchial secretion during bronchoscopy: A randomized controlled trial.
Wang F, Zheng H, Zhang Y, Zhu H, Shi J, Luo Y, Zhang X, Mao H, Herth FJF, Luo F. Wang F, et al. Medicine (Baltimore). 2019 Nov;98(47):e17942. doi: 10.1097/MD.0000000000017942. Medicine (Baltimore). 2019. PMID: 31764793 Free PMC article. Clinical Trial.
METHODS: Patients were randomized 1:1 to receive nebulized 4 ml ipratropium bromide (1 mg, n = 125) or placebo (n = 125) for 15 minutes as premedication, 20 to 40 minutes before bronchoscopy. ...We suggest that routine nebulized ipratropium bromide premedication for …
METHODS: Patients were randomized 1:1 to receive nebulized 4 ml ipratropium bromide (1 mg, n = 125) or placebo (n = 125) for 15 minut …
936 results